Drug Type Small molecule drug |
Synonyms- |
Target |
Action degraders |
Mechanism KAT2A degraders(lysine acetyltransferase 2A degraders), KAT2B degraders(lysine acetyltransferase 2B degraders), Epigenetic drug |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Asthma | Discovery | United States | 01 Apr 2025 | |
| Inflammatory Bowel Diseases | Discovery | United States | 01 Apr 2025 | |
| Rheumatoid Arthritis | Discovery | United States | 01 Apr 2025 |





